US Stock MarketDetailed Quotes

ORGO Organogenesis

Watchlist
  • 2.550
  • +0.060+2.41%
Trading May 3 12:49 ET
338.06MMarket Cap63.75P/E (TTM)

About Organogenesis Company

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Company Profile

SymbolORGO
Company NameOrganogenesis
Listing DateDec 2, 2016
Founded1985
CEOMr. Gary S. Gillheeney, Sr
MarketNASDAQ
Employees862
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address85 Dan Road
CityCanton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02021
Phone1-781-575-0775
Websitehttp://www.organogenesis.com

Company Executives

  • Name
  • Position
  • Salary
  • Gary S. Gillheeney, Sr
  • Chairman of the Board, President and Chief Executive Officer
  • 6.01M
  • Lori Freedman
  • Chief Administrative and Legal Officer, Vice President and General Counsel
  • 1.23M
  • Brian Grow
  • Chief Commercial Officer
  • 1.31M
  • David C. Francisco
  • Chief Financial Officer and Principal Accounting Officer
  • 1.19M
  • Patrick Bilbo
  • Chief Operating Officer
  • 1.47M
  • Antonio S. Montecalvo
  • Vice President, Health Policy
  • --
  • David Erani
  • Director
  • --
  • Alan A. Ades
  • Director
  • --
  • Robert Ades
  • Director
  • --
  • Glenn H. Nussdorf
  • Director
  • --
  • Gilberto Quintero
  • Independent Director
  • 201.11K
  • Dr. Michael Joseph Driscoll
  • Independent Director
  • 227.54K
  • Michele Korfin
  • Independent Director
  • 201.11K
  • Jon L. Giacomin
  • Independent Director
  • 261.73K
  • Arthur S. Leibowitz
  • Lead Independent Director
  • 293.13K
  • Prathyusha Duraibabu
  • Independent Director
  • 236.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg